Welcome to
Sysmex Flow Cytometry Other European Country!

For ordering please make sure you are in your local shop.
If you are from Other European Country then please continue.
Otherwise please go to your country.

Go to my country Continue

Article successfully added.

CyFlow™ CD90.2 Azide Free

CyFlow™ CD90.2 Azide Free
Antigen: CD90.2
Clone: 1aG4/C5
Application: Flow cytometry, Functional assays, Immunocytochemistry, Western blot
Format/Fluorochrome: Azide Free
Target Species: Mouse
Field of Interest: Immunophenotyping, MHC
Species of Origin: Mouse
Regulatory Status: RUO
Clonality: monoclonal
Isotype: IgG3
Order number: BG951910

For Research Use Only
Not for use in diagnostic or therapeutic procedures.

Concentration Unit mg/mL Concentration 1 Quantity 0.1 mg Volume 0.1 Immunogen... more
CyFlow™ CD90.2 Azide Free
Concentration Unitmg/mL
Quantity0.1 mg
ImmunogenThymocytes from C3H/Di mice (Thy-1.2 positive)
Background InformationCD90 (Thy-1) is an 18-35 kDa GPI-anchored plasma membrane glycoprotein expressed in many cell types, such as in hematopoietic cells and neurons, connective tissues, various fibroblast and stromal cell lines, tumor endothelial cell lines and other. In the mouse, CD90 is expressed mainly on thymocytes and peripheral T lymphocytes. It is involved in T cell activation, cellular adhesion, proliferation and migration, neurite outgrowth, wound healing, apoptosis, and fibrosis. CD90 participates in multiple signaling cascades and its effects are tissue- and cell type-specific. It often functions as an important regulator of cell-cell and cell-matrix interactions.
Storage BufferThe reagent is provided in azide-free phosphate buffered saline (PBS) solution, pH ≈7.4; 0.2 µm filter sterilized.
StorageAvoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.
StabilityDo not use after expiration date stamped on vial label.
Specific References

| Draber P, Zikan J, Vogtiskova M: Establishment and characterization of permanent murine hybridomas secreting monoclonal anti‑thy‑1 antibodies. J·Immunogenet. 1980·Dec; 7(6):455‑74. <·PMID:·6787139·> | Zikan J, Draber P, Vojtiskova M: Monoclonal IgG3 (kappa) antibodies against murine Thy‑1.2 antigen produced by murine hybridomas: Differences in the specificity of the antigen binding site and in the structure of the hinge region. Folia·Biol·(Praha). 1982; 28(6):377‑94. <·PMID:·6186535·> | Draberova L, Draber P: Thy‑1 glycoprotein and src‑like protein‑tyrosine kinase p53/p56lyn are associated in large detergent‑resistant complexes in rat basophilic leukemiacells. Proc·Natl·Acad·Sci·USA. 1993·Apr·15; 90(8):3611‑5. <·PMID:·7682713·> | Haeryfar SM, Hoskin DW: Thy‑1: more than a mouse pan‑T cell marker. J·Immunol. 2004·Sep·15; 173(6):3581‑8. <·PMID:·15356100·> | Rege TA, Hagood JS: Thy‑1 as a regulator of cell‑cell and cell‑matrix interactions in axon regeneration, apoptosis, adhesion, migration, cancer, and fibrosis. FASEB·J. 2006·Jun; 20(8):1045‑54. <·PMID:·16770003·> | Heneberg P, Lebduska P, Draberova L, Korb J, Draber P: Topography of plasma membrane microdomains and its consequences for mast cell signaling. Eur·J·Immunol. 2006·Oct; 36(10):2795‑806. <·PMID:·17013982·> | Rege TA, Hagood JS: Thy‑1, a versatile modulator of signaling affecting cellular adhesion, proliferation, survival, and cytokine/growth factor responses. Biochim·Biophys·Acta. 2006·Oct; 1763(10):991‑9. <·PMID:·16996153·> | Bradley JE, Ramirez G, Hagood JS: Roles and regulation of Thy‑1, a context‑dependent modulator of cell phenotype. Biofactors. 2009·May-Jun; 35(3):258‑65. <·PMID:·19422052·>